MLTX
insider transactionsMoonLake Immunotherapeutics — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-167.9K
0 buy · 167.9K sell
Net value · 30d
-$3.2M
$0 in · $3.2M out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
5
0 buy · 167.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Chief Financial Officer · 10b5-1
$54.8K
2.8K sh · $19.60
Own -0%
-
Sell·S
Chief Scientific Officer · 10b5-1
$971.5K
50.0K sh · $19.43
Own -2%
-
Grant·A
Director
$0
22.2K sh
Own New
-
Grant·A
Director
$0
22.2K sh
Own New
-
Grant·A
Director
$0
22.2K sh
Own New
-
Grant·A
Director
$0
22.2K sh
Own New
-
Sell·S
Chief Financial Officer · 10b5-1
$296.8K
15.1K sh · $19.68
Own -1%
-
Sell·S
Chief Scientific Officer · 10b5-1
$935.0K
50.0K sh · $18.70
Own -2%
-
Sell·S
Chief Scientific Officer · 10b5-1
$944.5K
50.0K sh · $18.89
Own -2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Matthias Bodenstedt KEY 10b5-1 | Sell S | 2.8K | $54.8K |
| Jun 17, 2026 | Kristian Reich 10b5-1 | Sell S | 50.0K | $971.5K |
| Jun 17, 2026 | Andrew John Phillips | Grant A | 22.2K | $0 |
| Jun 17, 2026 | Catherine Moukheibir | Grant A | 22.2K | $0 |
| Jun 17, 2026 | Ramnik Xavier | Grant A | 22.2K | $0 |
| Jun 17, 2026 | Spike Loy | Grant A | 22.2K | $0 |
| Jun 17, 2026 | Matthias Bodenstedt KEY 10b5-1 | Sell S | 15.1K | $296.8K |
| Jun 16, 2026 | Kristian Reich 10b5-1 | Sell S | 50.0K | $935.0K |
| Jun 15, 2026 | Kristian Reich 10b5-1 | Sell S | 50.0K | $944.5K |
About MLTX insider trading
This page tracks insider transactions for MoonLake Immunotherapeutics (MLTX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.